Evolve
Device Trauma & Extremities
PDI 00840420116062
General payments
$401,868
Research payments
$3,616
Through program year 2025, $401,868 in general payments and $3,616 in research payments were reported against Evolve (Trauma & Extremities).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $71,111 | 625 |
| 2025 | Research | $2,756 | 1 |
| 2024 | General | $127,597 | 425 |
| 2023 | General | $77,745 | 310 |
| 2023 | Research | $860 | 1 |
| 2022 | General | $93,939 | 349 |
| 2021 | General | $31,476 | 109 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,818 general · 2 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.